Conference: Precision Attends ISPOR
Precision will be sharing exciting information at ISPOR 2024! Reach out to schedule time with one of our experts to learn more.
CLICK HERE to connect with our team!
Precision will be sharing exciting information at ISPOR 2024! Reach out to schedule time with one of our experts to learn more.
CLICK HERE to connect with our team!
Precision will be sharing exciting information at ISPOR 2024! Schedule time with one of our experts to see how we can help you tackle your biggest HEOR challenges.
CLICK HERE to connect with our team!
The PV&H May Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Learn how EHR treatment plans and clinical pathways are leveraged to prefer or restrict access to different products.
Our panel will explore different platforms and EHR systems to help manufacturers better understand how community and academic oncology providers “manage” drug regimens.
The PV&H April Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
We’re thrilled to announce that Charline Shan, Vice President of Strategic Consulting, has been named on MM+M’s 2024 Women to Watch list! A pharmacist turned strategic powerhouse, Charline excels at decoding the complex web of value in healthcare, shaping pre-launch success, and championing women in the industry.
The PV&H March Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors’ inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life.
The firm secured rankings in four distinct categories:
The COVID-19 pandemic laid bare disparities in access to quality healthcare and resources that have led to poor outcomes among racial and ethnic minorities, socioeconomically vulnerable individuals, and populations in rural areas. With a renewed and keener scrutiny of health equity issues, the distributional consequences of a new intervention across subgroups should come to the forefront of discussions about value in health.
Join Precision HEOR for a webinar about studying the health equity impacts of new interventions. We will outline the conceptual basis of how health interventions can affect health equity and consider distributional cost-effectiveness analysis with decision-analytic models as a practical approach to assess this quantitatively. We will discuss the evidence needs and typical gaps for new interventions and how to optimize the use of existing data. The discussion will conclude with a live Q&A.
This webinar will focus on the implications of the Inflation Reduction Act (IRA) on value proposition development and the evidence needed for drugs launching in 2027-2028 that plan to seek reimbursement from Medicare. Join PRECISIONvalue’s Andrew Cournoyer and Precision Value & Health’s Ross Maclean for this value packed webinar.